APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preclinical Pharmacokinetics Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Preclinical Pharmacokinetics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

6 March 2026196 pages

Choose your research edition.

Industry ResearchPreclinical Pharmacokinetics Services Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Preclinical Pharmacokinetics Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Preclinical Pharmacokinetics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preclinical Pharmacokinetics Services Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Preclinical Pharmacokinetics Services Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Preclinical Pharmacokinetics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Preclinical Pharmacokinetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Preclinical Pharmacokinetics Services include Porsolt, Altasciences, Biocytogen, Charles River Laboratories, WuXi AppTec, PyschoGenics, Evotec (Cyprotex), QPS and Aurigene Pharmaceutical Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Preclinical Pharmacokinetics Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Preclinical Pharmacokinetics Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Preclinical Pharmacokinetics Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Preclinical Pharmacokinetics Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Preclinical Pharmacokinetics Services Segment by Company

Porsolt

Altasciences

Biocytogen

Charles River Laboratories

WuXi AppTec

PyschoGenics

Evotec (Cyprotex)

QPS

Aurigene Pharmaceutical Services

Frontage Laboratories

Dalriada

Sygnature Discovery

Admescope

Imavita

IQVIA Laboratories

Pharmaron

Preclinical Pharmacokinetics Services Segment by Type

LC-MS/MS-Based Preclinical Pharmacokinetics Service

Immunoassay-Based Preclinical Pharmacokinetics Service

Others

Preclinical Pharmacokinetics Services Segment by Application

Innovative Small Molecule Drugs

Biopharmaceuticals

Traditional Chinese Medicine & Natural Products

Others

Preclinical Pharmacokinetics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preclinical Pharmacokinetics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preclinical Pharmacokinetics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preclinical Pharmacokinetics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Preclinical Pharmacokinetics Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Preclinical Pharmacokinetics Services industry.

Chapter 3: Detailed analysis of Preclinical Pharmacokinetics Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preclinical Pharmacokinetics Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of LC-MS/MS-Based Preclinical Pharmacokinetics Service Table 3. Key Players of Immunoassay-Based Preclinical Pharmacokinetics Service Table 4. Key Players of Others Table 4. Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Innovative Small Molecule Drugs Table 6. Key Players of Biopharmaceuticals Table 7. Key Players of Traditional Chinese Medicine & Natural Products Table 8. Key Players of Others Table 9. Global Preclinical Pharmacokinetics Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Preclinical Pharmacokinetics Services Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Preclinical Pharmacokinetics Services Market Share by Region (2021-2026) Table 12. Global Preclinical Pharmacokinetics Services Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Preclinical Pharmacokinetics Services Market Share by Region (2027-2032) Table 14. Preclinical Pharmacokinetics Services Industry Trends Table 15. Preclinical Pharmacokinetics Services Industry Drivers Table 16. Preclinical Pharmacokinetics Services Industry Opportunities and Challenges Table 17. Preclinical Pharmacokinetics Services Industry Restraints Table 18. Global Preclinical Pharmacokinetics Services Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Preclinical Pharmacokinetics Services Revenue Market Share by Company (2021-2026) Table 20. Global Preclinical Pharmacokinetics Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Preclinical Pharmacokinetics Services Key Company Head Office and Area Served Table 22. Global Preclinical Pharmacokinetics Services Company, Product Type & Application Table 23. Global Preclinical Pharmacokinetics Services Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Preclinical Pharmacokinetics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Preclinical Pharmacokinetics Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Preclinical Pharmacokinetics Services Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Preclinical Pharmacokinetics Services Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Preclinical Pharmacokinetics Services Revenue Market Share by Type (2021-2026) Table 30. Global Preclinical Pharmacokinetics Services Revenue Market Share by Type (2027-2032) Table 31. Global Preclinical Pharmacokinetics Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Preclinical Pharmacokinetics Services Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Preclinical Pharmacokinetics Services Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Preclinical Pharmacokinetics Services Revenue Market Share by Application (2021-2026) Table 35. Global Preclinical Pharmacokinetics Services Revenue Market Share by Application (2027-2032) Table 36. Porsolt Company Information Table 37. Porsolt Business Overview Table 38. Porsolt Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Porsolt Preclinical Pharmacokinetics Services Product Portfolio Table 40. Porsolt Recent Development Table 41. Altasciences Company Information Table 42. Altasciences Business Overview Table 43. Altasciences Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Altasciences Preclinical Pharmacokinetics Services Product Portfolio Table 45. Altasciences Recent Development Table 46. Biocytogen Company Information Table 47. Biocytogen Business Overview Table 48. Biocytogen Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Biocytogen Preclinical Pharmacokinetics Services Product Portfolio Table 50. Biocytogen Recent Development Table 51. Charles River Laboratories Company Information Table 52. Charles River Laboratories Business Overview Table 53. Charles River Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Charles River Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 55. Charles River Laboratories Recent Development Table 56. WuXi AppTec Company Information Table 57. WuXi AppTec Business Overview Table 58. WuXi AppTec Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. WuXi AppTec Preclinical Pharmacokinetics Services Product Portfolio Table 60. WuXi AppTec Recent Development Table 61. PyschoGenics Company Information Table 62. PyschoGenics Business Overview Table 63. PyschoGenics Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. PyschoGenics Preclinical Pharmacokinetics Services Product Portfolio Table 65. PyschoGenics Recent Development Table 66. Evotec (Cyprotex) Company Information Table 67. Evotec (Cyprotex) Business Overview Table 68. Evotec (Cyprotex) Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Evotec (Cyprotex) Preclinical Pharmacokinetics Services Product Portfolio Table 70. Evotec (Cyprotex) Recent Development Table 71. QPS Company Information Table 72. QPS Business Overview Table 73. QPS Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. QPS Preclinical Pharmacokinetics Services Product Portfolio Table 75. QPS Recent Development Table 76. Aurigene Pharmaceutical Services Company Information Table 77. Aurigene Pharmaceutical Services Business Overview Table 78. Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Product Portfolio Table 80. Aurigene Pharmaceutical Services Recent Development Table 81. Frontage Laboratories Company Information Table 82. Frontage Laboratories Business Overview Table 83. Frontage Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Frontage Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 85. Frontage Laboratories Recent Development Table 86. Dalriada Company Information Table 87. Dalriada Business Overview Table 88. Dalriada Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Dalriada Preclinical Pharmacokinetics Services Product Portfolio Table 90. Dalriada Recent Development Table 91. Sygnature Discovery Company Information Table 92. Sygnature Discovery Business Overview Table 93. Sygnature Discovery Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Sygnature Discovery Preclinical Pharmacokinetics Services Product Portfolio Table 95. Sygnature Discovery Recent Development Table 96. Admescope Company Information Table 97. Admescope Business Overview Table 98. Admescope Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Admescope Preclinical Pharmacokinetics Services Product Portfolio Table 100. Admescope Recent Development Table 101. Imavita Company Information Table 102. Imavita Business Overview Table 103. Imavita Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Imavita Preclinical Pharmacokinetics Services Product Portfolio Table 105. Imavita Recent Development Table 106. IQVIA Laboratories Company Information Table 107. IQVIA Laboratories Business Overview Table 108. IQVIA Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. IQVIA Laboratories Preclinical Pharmacokinetics Services Product Portfolio Table 110. IQVIA Laboratories Recent Development Table 111. Pharmaron Company Information Table 112. Pharmaron Business Overview Table 113. Pharmaron Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Pharmaron Preclinical Pharmacokinetics Services Product Portfolio Table 115. Pharmaron Recent Development Table 116. North America Preclinical Pharmacokinetics Services Market Size by Type (2021-2026) & (US$ Million) Table 117. North America Preclinical Pharmacokinetics Services Market Size by Type (2027-2032) & (US$ Million) Table 118. North America Preclinical Pharmacokinetics Services Market Size by Application (2021-2026) & (US$ Million) Table 119. North America Preclinical Pharmacokinetics Services Market Size by Application (2027-2032) & (US$ Million) Table 120. North America Preclinical Pharmacokinetics Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) Table 122. North America Preclinical Pharmacokinetics Services Market Size by Country (2027-2032) Table 123. Europe Preclinical Pharmacokinetics Services Market Size by Type (2021-2026) & (US$ Million) Table 124. Europe Preclinical Pharmacokinetics Services Market Size by Type (2027-2032) & (US$ Million) Table 125. Europe Preclinical Pharmacokinetics Services Market Size by Application (2021-2026) & (US$ Million) Table 126. Europe Preclinical Pharmacokinetics Services Market Size by Application (2027-2032) & (US$ Million) Table 127. Europe Preclinical Pharmacokinetics Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) Table 129. Europe Preclinical Pharmacokinetics Services Market Size by Country (2027-2032) Table 130. China Preclinical Pharmacokinetics Services Market Size by Type (2021-2026) & (US$ Million) Table 131. China Preclinical Pharmacokinetics Services Market Size by Type (2027-2032) & (US$ Million) Table 132. China Preclinical Pharmacokinetics Services Market Size by Application (2021-2026) & (US$ Million) Table 133. China Preclinical Pharmacokinetics Services Market Size by Application (2027-2032) & (US$ Million) Table 134. Asia Preclinical Pharmacokinetics Services Market Size by Type (2021-2026) & (US$ Million) Table 135. Asia Preclinical Pharmacokinetics Services Market Size by Type (2027-2032) & (US$ Million) Table 136. Asia Preclinical Pharmacokinetics Services Market Size by Application (2021-2026) & (US$ Million) Table 137. Asia Preclinical Pharmacokinetics Services Market Size by Application (2027-2032) & (US$ Million) Table 138. Asia Preclinical Pharmacokinetics Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) Table 140. Asia Preclinical Pharmacokinetics Services Market Size by Country (2027-2032) Table 141. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Type (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Type (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Application (2021-2026) & (US$ Million) Table 144. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Application (2027-2032) & (US$ Million) Table 145. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2021-2026) Table 147. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Preclinical Pharmacokinetics Services Product Image Figure 2. Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Preclinical Pharmacokinetics Services Market Share by Type: 2025 VS 2032 Figure 4. LC-MS/MS-Based Preclinical Pharmacokinetics Service Image Figure 5. Immunoassay-Based Preclinical Pharmacokinetics Service Image Figure 6. Others Image Figure 7. Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Preclinical Pharmacokinetics Services Market Share by Application: 2025 VS 2032 Figure 9. Innovative Small Molecule Drugs Image Figure 10. Biopharmaceuticals Image Figure 11. Traditional Chinese Medicine & Natural Products Image Figure 12. Others Image Figure 13. Global Preclinical Pharmacokinetics Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 15. Global Preclinical Pharmacokinetics Services Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Preclinical Pharmacokinetics Services Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Preclinical Pharmacokinetics Services Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Preclinical Pharmacokinetics Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Preclinical Pharmacokinetics Services Revenue Market Share by Type (2021-2032) Figure 22. Global Preclinical Pharmacokinetics Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Preclinical Pharmacokinetics Services Revenue Market Share by Application (2021-2032) Figure 24. North America Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 25. North America Preclinical Pharmacokinetics Services Market Share by Type (2021-2032) Figure 26. North America Preclinical Pharmacokinetics Services Market Share by Application (2021-2032) Figure 27. North America Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 28. United States Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 29. Canada Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 31. Europe Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Preclinical Pharmacokinetics Services Market Share by Type (2021-2032) Figure 33. Europe Preclinical Pharmacokinetics Services Market Share by Application (2021-2032) Figure 34. Europe Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 35. Germany Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 36. France Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 38. Italy Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 39. Russia Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 41. China Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 42. China Preclinical Pharmacokinetics Services Market Share by Type (2021-2032) Figure 43. China Preclinical Pharmacokinetics Services Market Share by Application (2021-2032) Figure 44. Asia Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 45. Asia Preclinical Pharmacokinetics Services Market Share by Type (2021-2032) Figure 46. Asia Preclinical Pharmacokinetics Services Market Share by Application (2021-2032) Figure 47. Asia Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 48. Japan Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 52. India Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 53. Australia Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Country (2021-2032) Figure 58. Brazil Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 63. UAE Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 65. Chile Preclinical Pharmacokinetics Services Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • LC-MS/MS-Based Preclinical Pharmacokinetics Service
  • Immunoassay-Based Preclinical Pharmacokinetics Service
  • Others
Applications
  • Innovative Small Molecule Drugs
  • Biopharmaceuticals
  • Traditional Chinese Medicine & Natural Products
  • Others
Companies covered
  • Porsolt
  • Altasciences
  • Biocytogen
  • Charles River Laboratories
  • WuXi AppTec
  • PyschoGenics
  • Evotec (Cyprotex)
  • QPS
  • Aurigene Pharmaceutical Services
  • Frontage Laboratories
  • Dalriada
  • Sygnature Discovery
  • Admescope
  • Imavita
  • IQVIA Laboratories
  • Pharmaron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 LC-MS/MS-Based Preclinical Pharmacokinetics Service
  5. 1.2.3 Immunoassay-Based Preclinical Pharmacokinetics Service
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Preclinical Pharmacokinetics Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Innovative Small Molecule Drugs
  10. 1.3.3 Biopharmaceuticals
  11. 1.3.4 Traditional Chinese Medicine & Natural Products
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Preclinical Pharmacokinetics Services Growth Trends by Region
  15. 1.5.1 Global Preclinical Pharmacokinetics Services Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Preclinical Pharmacokinetics Services Market Size by Region (2021-2026)
  17. 1.5.3 Preclinical Pharmacokinetics Services Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Preclinical Pharmacokinetics Services Market Dynamics
  1. 2.1 Preclinical Pharmacokinetics Services Industry Trends
  2. 2.2 Preclinical Pharmacokinetics Services Industry Drivers
  3. 2.3 Preclinical Pharmacokinetics Services Industry Opportunities and Challenges
  4. 2.4 Preclinical Pharmacokinetics Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Preclinical Pharmacokinetics Services Revenue by Company (2021-2026)
  2. 3.2 Global Preclinical Pharmacokinetics Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Preclinical Pharmacokinetics Services Key Company Head office and Area Served
  4. 3.4 Global Preclinical Pharmacokinetics Services Company, Product Type & Application
  5. 3.5 Global Preclinical Pharmacokinetics Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Preclinical Pharmacokinetics Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Preclinical Pharmacokinetics Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Preclinical Pharmacokinetics Services Tier 1, Tier 2, and Tier 3
4 Preclinical Pharmacokinetics Services Market by Type
  1. 4.1 Global Preclinical Pharmacokinetics Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Preclinical Pharmacokinetics Services Market Size by Type (2021-2032)
  3. 4.3 Global Preclinical Pharmacokinetics Services Market Size Share by Type (2021-2032)
5 Preclinical Pharmacokinetics Services Market by Application
  1. 5.1 Global Preclinical Pharmacokinetics Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Preclinical Pharmacokinetics Services Market Size by Application (2021-2032)
  3. 5.3 Global Preclinical Pharmacokinetics Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Porsolt
  2. 6.1.1 Porsolt Company Information
  3. 6.1.2 Porsolt Business Overview
  4. 6.1.3 Porsolt Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Porsolt Preclinical Pharmacokinetics Services Product Portfolio
  6. 6.1.5 Porsolt Recent Developments
  7. 6.2 Altasciences
  8. 6.2.1 Altasciences Company Information
  9. 6.2.2 Altasciences Business Overview
  10. 6.2.3 Altasciences Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Altasciences Preclinical Pharmacokinetics Services Product Portfolio
  12. 6.2.5 Altasciences Recent Developments
  13. 6.3 Biocytogen
  14. 6.3.1 Biocytogen Company Information
  15. 6.3.2 Biocytogen Business Overview
  16. 6.3.3 Biocytogen Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Biocytogen Preclinical Pharmacokinetics Services Product Portfolio
  18. 6.3.5 Biocytogen Recent Developments
  19. 6.4 Charles River Laboratories
  20. 6.4.1 Charles River Laboratories Company Information
  21. 6.4.2 Charles River Laboratories Business Overview
  22. 6.4.3 Charles River Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Charles River Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  24. 6.4.5 Charles River Laboratories Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 WuXi AppTec Preclinical Pharmacokinetics Services Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 PyschoGenics
  32. 6.6.1 PyschoGenics Company Information
  33. 6.6.2 PyschoGenics Business Overview
  34. 6.6.3 PyschoGenics Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 PyschoGenics Preclinical Pharmacokinetics Services Product Portfolio
  36. 6.6.5 PyschoGenics Recent Developments
  37. 6.7 Evotec (Cyprotex)
  38. 6.7.1 Evotec (Cyprotex) Company Information
  39. 6.7.2 Evotec (Cyprotex) Business Overview
  40. 6.7.3 Evotec (Cyprotex) Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Evotec (Cyprotex) Preclinical Pharmacokinetics Services Product Portfolio
  42. 6.7.5 Evotec (Cyprotex) Recent Developments
  43. 6.8 QPS
  44. 6.8.1 QPS Company Information
  45. 6.8.2 QPS Business Overview
  46. 6.8.3 QPS Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 QPS Preclinical Pharmacokinetics Services Product Portfolio
  48. 6.8.5 QPS Recent Developments
  49. 6.9 Aurigene Pharmaceutical Services
  50. 6.9.1 Aurigene Pharmaceutical Services Company Information
  51. 6.9.2 Aurigene Pharmaceutical Services Business Overview
  52. 6.9.3 Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Aurigene Pharmaceutical Services Preclinical Pharmacokinetics Services Product Portfolio
  54. 6.9.5 Aurigene Pharmaceutical Services Recent Developments
  55. 6.10 Frontage Laboratories
  56. 6.10.1 Frontage Laboratories Company Information
  57. 6.10.2 Frontage Laboratories Business Overview
  58. 6.10.3 Frontage Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Frontage Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  60. 6.10.5 Frontage Laboratories Recent Developments
  61. 6.11 Dalriada
  62. 6.11.1 Dalriada Company Information
  63. 6.11.2 Dalriada Business Overview
  64. 6.11.3 Dalriada Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Dalriada Preclinical Pharmacokinetics Services Product Portfolio
  66. 6.11.5 Dalriada Recent Developments
  67. 6.12 Sygnature Discovery
  68. 6.12.1 Sygnature Discovery Company Information
  69. 6.12.2 Sygnature Discovery Business Overview
  70. 6.12.3 Sygnature Discovery Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Sygnature Discovery Preclinical Pharmacokinetics Services Product Portfolio
  72. 6.12.5 Sygnature Discovery Recent Developments
  73. 6.13 Admescope
  74. 6.13.1 Admescope Company Information
  75. 6.13.2 Admescope Business Overview
  76. 6.13.3 Admescope Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Admescope Preclinical Pharmacokinetics Services Product Portfolio
  78. 6.13.5 Admescope Recent Developments
  79. 6.14 Imavita
  80. 6.14.1 Imavita Company Information
  81. 6.14.2 Imavita Business Overview
  82. 6.14.3 Imavita Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Imavita Preclinical Pharmacokinetics Services Product Portfolio
  84. 6.14.5 Imavita Recent Developments
  85. 6.15 IQVIA Laboratories
  86. 6.15.1 IQVIA Laboratories Company Information
  87. 6.15.2 IQVIA Laboratories Business Overview
  88. 6.15.3 IQVIA Laboratories Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 IQVIA Laboratories Preclinical Pharmacokinetics Services Product Portfolio
  90. 6.15.5 IQVIA Laboratories Recent Developments
  91. 6.16 Pharmaron
  92. 6.16.1 Pharmaron Company Information
  93. 6.16.2 Pharmaron Business Overview
  94. 6.16.3 Pharmaron Preclinical Pharmacokinetics Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Pharmaron Preclinical Pharmacokinetics Services Product Portfolio
  96. 6.16.5 Pharmaron Recent Developments
7 North America
  1. 7.1 North America Preclinical Pharmacokinetics Services Market Size (2021-2032)
  2. 7.2 North America Preclinical Pharmacokinetics Services Market Size by Type
  3. 7.2.1 North America Preclinical Pharmacokinetics Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Preclinical Pharmacokinetics Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Preclinical Pharmacokinetics Services Market Share by Type (2021-2032)
  6. 7.3 North America Preclinical Pharmacokinetics Services Market Size by Application
  7. 7.3.1 North America Preclinical Pharmacokinetics Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Preclinical Pharmacokinetics Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Preclinical Pharmacokinetics Services Market Share by Application (2021-2032)
  10. 7.4 North America Preclinical Pharmacokinetics Services Market Size by Country
  11. 7.4.1 North America Preclinical Pharmacokinetics Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Preclinical Pharmacokinetics Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Preclinical Pharmacokinetics Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Preclinical Pharmacokinetics Services Market Size (2021-2032)
  2. 8.2 Europe Preclinical Pharmacokinetics Services Market Size by Type
  3. 8.2.1 Europe Preclinical Pharmacokinetics Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Preclinical Pharmacokinetics Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Preclinical Pharmacokinetics Services Market Share by Type (2021-2032)
  6. 8.3 Europe Preclinical Pharmacokinetics Services Market Size by Application
  7. 8.3.1 Europe Preclinical Pharmacokinetics Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Preclinical Pharmacokinetics Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Preclinical Pharmacokinetics Services Market Share by Application (2021-2032)
  10. 8.4 Europe Preclinical Pharmacokinetics Services Market Size by Country
  11. 8.4.1 Europe Preclinical Pharmacokinetics Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Preclinical Pharmacokinetics Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Preclinical Pharmacokinetics Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Preclinical Pharmacokinetics Services Market Size (2021-2032)
  2. 9.2 China Preclinical Pharmacokinetics Services Market Size by Type
  3. 9.2.1 China Preclinical Pharmacokinetics Services Market Size by Type (2021-2026)
  4. 9.2.2 China Preclinical Pharmacokinetics Services Market Size by Type (2027-2032)
  5. 9.2.3 China Preclinical Pharmacokinetics Services Market Share by Type (2021-2032)
  6. 9.3 China Preclinical Pharmacokinetics Services Market Size by Application
  7. 9.3.1 China Preclinical Pharmacokinetics Services Market Size by Application (2021-2026)
  8. 9.3.2 China Preclinical Pharmacokinetics Services Market Size by Application (2027-2032)
  9. 9.3.3 China Preclinical Pharmacokinetics Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Preclinical Pharmacokinetics Services Market Size (2021-2032)
  2. 10.2 Asia Preclinical Pharmacokinetics Services Market Size by Type
  3. 10.2.1 Asia Preclinical Pharmacokinetics Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Preclinical Pharmacokinetics Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Preclinical Pharmacokinetics Services Market Share by Type (2021-2032)
  6. 10.3 Asia Preclinical Pharmacokinetics Services Market Size by Application
  7. 10.3.1 Asia Preclinical Pharmacokinetics Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Preclinical Pharmacokinetics Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Preclinical Pharmacokinetics Services Market Share by Application (2021-2032)
  10. 10.4 Asia Preclinical Pharmacokinetics Services Market Size by Country
  11. 10.4.1 Asia Preclinical Pharmacokinetics Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Preclinical Pharmacokinetics Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Preclinical Pharmacokinetics Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Preclinical Pharmacokinetics Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst